News
Brain tumors are not only treatable but potentially curable with the evolving therapies explains Dr V Naveen Reddy from ...
A five-day water-only fast led to significant weight, fat, and lean muscle loss in middle-aged women, along with improved ...
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients are opting for it.
Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge cancer care closer to patients in ...
While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain.
During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients ...
Mark J. Bachleda, PharmD, MBA appointed as independent member of the Board of DirectorsDavid Shook, MD appointed as Chief ...
13h
healthdigest.com on MSNAn Experimental Treatment That Helped Cancer Patients Live 40% Longer Had One Noticeable Side EffectA new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...
Northwell Health unveiled a $1.1 million, 2,400-square-foot expansion of outpatient infusion at the R.J. Zuckerberg Cancer ...
Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...
Taiwan Cell Manufacturing Company (tcmc), a leading Contract Development and Manufacturing Organization (CDMO) in cell and ...
'We are in a good spot': Gilead's new chief medical officer is committed to pipeline diversification
Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results